サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1793718

医師オフィス診断の世界市場

Physician Office Diagnostics

出版日
ページ情報
英文 299 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
医師オフィス診断の世界市場
出版日: 2025年08月19日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 299 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医師オフィス診断の世界市場は2030年までに2億3,650万米ドルに達する見込み

2024年に1億1,590万米ドルと推定される医師オフィス診断の世界市場は、2030年には2億3,650万米ドルに達し、分析期間2024-2030年のCAGRは12.6%で成長すると予測されます。本レポートで分析したセグメントの1つであるPoint-of-Care Testing Devicesは、CAGR 14.6%を記録し、分析期間終了時には1億1,410万米ドルに達すると予測されます。臨床化学分析装置セグメントの成長率は、分析期間中CAGR 10.1%と推定されます。

米国市場は推定3,160万米ドル、中国はCAGR17.3％で成長予測

米国の医師オフィス診断市場は、2024年には3,160万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 17.3%で推移し、2030年には予測市場規模5,060万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.0％と11.4％と予測されています。欧州では、ドイツがCAGR 10.0%で成長すると予測されています。

世界の医師オフィス診断市場- 主要動向と促進要因まとめ

なぜオフィス内診断が医療機関や患者の間で選好されているのか？

医師オフィス診断は、定期的な受診時に実施される幅広い検査を網羅し、タイムリーな診断と治療の決定を可能にします。血液検査、尿検査、心電図、画像診断、迅速抗原検査、ポイントオブケア分析装置などが含まれます。現場での診断の利便性は、臨床効率、患者のコンプライアンス、診断所要時間を向上させる。

糖尿病、呼吸器感染症、心血管疾患、性感染症などの診断ツールに投資する医師も増えています。これらのツールは、プライマリ・ケアや緊急医療の現場で特に重要な、外部検査室への訪問やフォローアップ予約の必要性を減らすのに役立ちます。結果を即座に提供できることは、患者の満足度を高め、即日治療開始を可能にします。

プライマリ・ケアの現場をサポートする診断技術はどのように進化しているのか？

最新の医師オフィス診断は、最小限のサンプル調製で正確な結果を提供する、コンパクトで使いやすい機器に焦点を当てています。現在、POC検査プラットフォームには、免疫測定法、分子診断法、小規模診療所向けに設計されたデジタル画像診断ツールが含まれます。ワイヤレス接続を備えた自動分析装置は、ワークフローを合理化し、文書化基準の遵守を確実にするために採用されています。

ウェアラブル診断機器やポータブル超音波診断機器もプライマリ・ケア診療に導入され、検査能力の拡大が可能になっています。クラウドに接続された診断プラットフォームは、電子カルテ（EHR）とのデータ統合を容易にし、ケアの継続性と集団健康の追跡を向上させる。ラテラルフロー技術、マイクロ流体工学、マルチプレックス検査の進歩により、診断スピードと精度がさらに向上しています。

どこで採用が拡大し、どの検査カテゴリーが最も活発か？

医師オフィス診断は、家庭医療、内科、小児科、救急医療で広く使用されています。慢性疾患管理、感染症検出、心血管リスクモニタリングをサポートする検査に対する需要が特に高いです。これには、HbA1c、脂質パネル、溶連菌検査、インフルエンザおよびCOVID-19検査、尿検査、心電図などが含まれます。

北米は、プライマリ・ケアの高度なインフラと償還支援により、依然として最大の市場です。しかし、プライマリ・ケア制度が拡大している欧州やアジア太平洋地域でも導入が進んでいます。予防検診や慢性疾患管理を改善する政府の取り組みも、オフィスベースのケア環境における診断アクセスを促進しています。

医師オフィス診断市場の成長は、いくつかの要因によって牽引されています。

医師オフィス診断市場の成長の原動力は、診療現場での迅速な診断検査に対する需要の高まり、慢性疾患の有病率の増加、小型のポイントオブケア技術の進歩です。自動分析装置の普及、電子医療システムとの統合、疾患別迅速検査の拡大などが普及を後押ししています。

また、医師は診療効率を高め、患者の待ち時間を短縮し、ケア連携を改善するために診断に投資しています。予防的スクリーニングや慢性疾患のモニタリングを支援する診療報酬の枠組みは、市場の安定性を強化しています。患者数が増加し、即時ケアへの期待が高まるにつれ、オフィス内診断薬への需要は都市部や地方のケア環境全体で増加し続けるものと思われます。

セグメント

製品タイプ（ポイントオブケア検査機器、臨床化学分析装置、免疫測定システム、分子診断装置、尿検査システム）;アプリケーション（感染症アプリケーション、心血管疾患アプリケーション、代謝疾患アプリケーション、がん診断アプリケーション、妊娠アプリケーション、不妊検査アプリケーション）

調査対象企業の例

  • Abbott Laboratories
  • Alere Inc.（Now Abbott）
  • BD（Becton, Dickinson and Co.）
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cepheid
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • HORIBA Medical
  • Labcorp
  • Nova Biomedical
  • Ortho Clinical Diagnostics
  • QuidelOrtho Corporation
  • Radiometer Medical
  • Randox Laboratories
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37734

Global Physician Office Diagnostics Market to Reach US$236.5 Million by 2030

The global market for Physician Office Diagnostics estimated at US$115.9 Million in the year 2024, is expected to reach US$236.5 Million by 2030, growing at a CAGR of 12.6% over the analysis period 2024-2030. Point-of-Care Testing Devices, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$114.1 Million by the end of the analysis period. Growth in the Clinical Chemistry Analyzers segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.6 Million While China is Forecast to Grow at 17.3% CAGR

The Physician Office Diagnostics market in the U.S. is estimated at US$31.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$50.6 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.0% CAGR.

Global Physician Office Diagnostics Market - Key Trends & Drivers Summarized

Why Are In-Office Diagnostics Gaining Preference Among Providers and Patients?

Physician office diagnostics encompass a wide range of tests conducted during a routine visit, allowing timely diagnosis and treatment decisions. These include blood tests, urinalysis, ECGs, imaging, rapid antigen tests, and point-of-care analyzers. The convenience of conducting diagnostics on-site improves clinical efficiency, patient compliance, and diagnostic turnaround times.

Physicians are increasingly investing in diagnostic tools for conditions such as diabetes, respiratory infections, cardiovascular disease, and sexually transmitted infections. These tools help reduce the need for external lab visits and follow-up appointments, particularly important in primary care and urgent care settings. The ability to deliver immediate results enhances patient satisfaction and enables same-day treatment initiation.

How Are Diagnostic Technologies Evolving to Support Primary Care Settings?

Modern physician office diagnostics focus on compact, user-friendly devices that offer accurate results with minimal sample preparation. Point-of-care testing platforms now include immunoassays, molecular diagnostics, and digital imaging tools designed for small practice environments. Automated analyzers with wireless connectivity are being adopted to streamline workflow and ensure compliance with documentation standards.

Wearable diagnostics and portable ultrasound devices are also entering primary care practices, enabling expanded examination capabilities. Cloud-connected diagnostic platforms facilitate data integration with electronic health records (EHRs), improving continuity of care and population health tracking. Advances in lateral flow technology, microfluidics, and multiplex testing are further enhancing diagnostic speed and precision.

Where Is Adoption Expanding and Which Test Categories Are Most Active?

Physician office diagnostics are widely used across family medicine, internal medicine, pediatrics, and urgent care. Demand is particularly high for tests that support chronic disease management, infectious disease detection, and cardiovascular risk monitoring. These include HbA1c, lipid panels, strep tests, flu and COVID-19 testing, urinalysis, and ECGs.

North America remains the largest market due to advanced primary care infrastructure and reimbursement support. However, adoption is growing in Europe and Asia-Pacific, where primary care systems are expanding. Government initiatives to improve preventive screening and chronic disease management are also promoting diagnostic access in office-based care environments.

Growth in the Physician Office Diagnostics market is driven by several factors…

Growth in the physician office diagnostics market is driven by the rising demand for rapid, in-practice diagnostic testing, increasing prevalence of chronic diseases, and advances in compact, point-of-care technologies. Broader use of automated analyzers, integration with electronic health systems, and expansion of disease-specific rapid tests are supporting adoption.

Physicians are also investing in diagnostics to enhance practice efficiency, reduce patient wait times, and improve care coordination. Reimbursement frameworks that support preventive screenings and chronic condition monitoring are strengthening market stability. As patient volume grows and expectations for immediate care rise, demand for in-office diagnostics is set to continue increasing across urban and rural care settings.

SCOPE OF STUDY:

The report analyzes the Physician Office Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, Urinalysis Systems); Application (Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application, Cancer Diagnosis Application, Pregnancy Application, Fertility Testing Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Alere Inc. (Now Abbott)
  • BD (Becton, Dickinson and Co.)
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cepheid
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • HORIBA Medical
  • Labcorp
  • Nova Biomedical
  • Ortho Clinical Diagnostics
  • QuidelOrtho Corporation
  • Radiometer Medical
  • Randox Laboratories
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Physician Office Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rapid and On-the-Spot Test Results Propels Growth in Physician Office Diagnostics
    • Shift Toward Decentralized Healthcare Delivery Expands the Role of In-Office Diagnostic Testing
    • Point-of-Care Technology Advancements Strengthen the Business Case for Diagnostic Equipment in Primary Care
    • Increasing Chronic Disease Burden Fuels Demand for Routine Testing and Real-Time Monitoring in Clinics
    • Patient Preference for Convenience and Faster Diagnosis Drives Adoption of In-Office Testing Solutions
    • Integration with Electronic Health Records (EHR) Enhances Workflow Efficiency and Diagnostic Accuracy
    • Growth in Preventive and Personalized Medicine Supports Expansion of Multi-Panel Diagnostic Tools
    • Cost Pressures and Value-Based Care Models Propel Use of In-House Diagnostics to Reduce Referrals and Delays
    • Miniaturization and Connectivity in Diagnostic Devices Enable Broader Use in Smaller Physician Practices
    • Expansion of Diagnostic Capabilities in Family and Internal Medicine Clinics Sustains Market Growth
    • Training and Ease-of-Use Improvements Drive Wider Adoption Among Non-Specialist Healthcare Providers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Physician Office Diagnostics Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Physician Office Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Point-of-Care Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Point-of-Care Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Point-of-Care Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urinalysis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urinalysis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Urinalysis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pregnancy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pregnancy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fertility Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Cardiovascular Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Metabolic Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Metabolic Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Metabolic Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Cancer Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Cancer Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Cancer Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • CHINA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Physician Office Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Physician Office Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • INDIA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Physician Office Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Physician Office Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030

IV. COMPETITION